Cita APA (7a ed.)
Putnam, J., Ullman, K., Zawislak, P., Schoneker, D., Collins, G., Muse, D. G., . . . Moreton, C. (2021). Understanding Concomitant Components in Pharmaceutical Excipients: Viewpoint: Continued dialogue among pharma stakeholders is needed to achieve consensus regarding excipient composition. Pharmaceutical Technology, 45(2), 49-54.
Cita Chicago Style (17a ed.)
Putnam, Jennifer, Katherine Ullman, Priscilla Zawislak, David Schoneker, George Collins, Douglas G. Muse, Brian Carlin, Joseph Zeleznik, y Chris Moreton. "Understanding Concomitant Components in Pharmaceutical Excipients: Viewpoint: Continued Dialogue Among Pharma Stakeholders Is Needed to Achieve Consensus Regarding Excipient Composition." Pharmaceutical Technology 45, no. 2 (2021): 49-54.
Cita MLA (9a ed.)
Putnam, Jennifer, et al. "Understanding Concomitant Components in Pharmaceutical Excipients: Viewpoint: Continued Dialogue Among Pharma Stakeholders Is Needed to Achieve Consensus Regarding Excipient Composition." Pharmaceutical Technology, vol. 45, no. 2, 2021, pp. 49-54.
Precaución: Estas citas no son 100% exactas.